Gd-DTPA-enhanced MR imaging in facial nerve paralysis
Creators
Description
GD-DTPA-enhanced MR imaging was used to evaluate 11 patients with facial nerve paralysis (five acute idiopathic facial palsy (Bell palsy), three chronic recurrent facial palsy, one acute facial palsy after local radiation therapy, one chronic facial dyskinesia, and one facial neuroma). In eight of 11 patients, there was marked enhancement of the infratemporal facial nerve from the labyrinthine segment to the stylomastoid foramen. Two patients had additional contrast enhancement in the internal auditory canal segment. In one patient, enhancement persisted (but to a lesser degree) 8 weeks after symptoms had resolved. In one patient, no enhancement was seen 15 months after resolution of Bell palsy. The facial neuroma was seen as a focal nodular enhancement in the mastoid segment of the facial nerve
Additional details
Publishing Information
- Publisher
- Radiological Society of North America Inc.
- Imprint Place
- Oak Brook, IL (USA)
- Imprint Title
- Proceedings of the 75th anniversary scientific assembly and annual meeting of the Radiological Society of North America (Abstracts)
- Imprint Pagination
- 654 p.
- Journal Page Range
- p. 144.
Conference
- Title
- 75. anniversary scientific assembly and annual meeting of the Radiological Society of North America.
- Dates
- 26 Nov - 1 Dec 1989.
- Place
- Chicago, IL (USA).
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 21071333
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Conference
- Descriptors DEI
- DIAGNOSIS; DTPA; FACE; GADOLINIUM; IMAGE INTENSIFIERS; NERVE TISSUE; NMR IMAGING; PATHOLOGICAL CHANGES
- Descriptors DEC
- AMINO ACIDS; BODY; BODY AREAS; CARBOXYLIC ACIDS; CHELATING AGENTS; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; ELEMENTS; HEAD; METALS; ORGANIC ACIDS; ORGANIC COMPOUNDS; RADIOPROTECTIVE SUBSTANCES; RARE EARTHS; RESPONSE MODIFYING FACTORS; TISSUES
Optional Information
- Secondary number(s)
- CONF-8911163--.